Mindset Pharma’s CEO talks about new lead drug candidate MSP-1014, a potentially safer next generation psilocybin alternative used to assist people suffering from treatment-resistant depression.
Psychable's Co-Founder and Chief Strategy Officer, Matt Zemon, shares details about the company's new "Buy One, Give One" ketamine-assisted therapy program.
Michelle Janikian, Author, Host and Editor at Psychedelics Today, discusses changing the narrative of psychedelics in the industry and her thoughts on personal magic mushroom use
Steven Huang, Diversity, Equity and Inclusion consultant at MAPS and Numinus shares his thoughts on building a more ethical and accountable future for the psychedelic industry.
Medicine Hunter Inc. Founder, Chris Kilham, shares his thoughts on the future cultivation of psychoactive plants and their healing potential on a larger scale.
Co-Founding Partner of The Conscious Fund, Henri Sant-Cassia, shares his thoughts on companies from the Fund’s portfolio.
19 min
About Psychedelic Spotlight Podcast
From the publisher's feed
Welcome the Psychedelic Spotlight Podcast! Blisteringly candid discussions with freaks of all feathers about psychedelics, plant medicine, biohacking and spirituality. Enjoy candid conversations with…
industry leaders and trusted professionals about research, spiritualty, harm reduction, and support.